Why the Ephesus Artemis
came to be a symbol for
this survivor e-zine?

April 2001
Subscribe | Archived Issues

Trastuzumab (Herceptin) Boosts Chemotherapy

A study just published in the New England Journal of Medicine has found that the HER2 monoclonal antibody called trastuzumab-more commonly known as Herceptin-may improve the effectiveness of chemotherapy for certain women with metastatic breast cancer.

Specifically, a team of California researchers found that trastuzumab appeared to make chemotherapy more effective in women whose breast cancer exhibits an overabundance ("overexpression") of a protein called HER2-which occurs in up to a third of all breast cancers.
Read full article

Complementary Approaches

Acupuncture to Alleviate Nausea

Vitamin A and Cancer

Vitamin C and Cancer

Other Features

Research Into Pain Management Lacking

Increasing Participation in Research Trials

Making Breast Surgery More Effective

Using MRI and Ultrasound to Detect Breast Cancer

Treating Anemia

FDA Cautious About Digital Mammograms

Developing Cancer Vaccines

Sticking with Mammograms...For Now

Understanding - and Overcoming - Neutropenia

Breast Reduction Surgery and Breast Cancer Risk

Tracking Environmental Chemicals

Relaxing to Reduce Risk?

Chemokines May Hold Key to Breast Cancer Spread

Reducing Weight to Reduce Risk

Coping with Sexual Concerns


If you would like to be notified of updates or changes to the Johns Hopkins Breast Center Web Site or to the Center's e-zine, Artemis, just enter your e-mail address here:

The Johns Hopkins Breast Center does not share email addresses of Artemis subscribers. We will send you an email once a month alerting you to the next issue being available for your review and also will inform you of general research trials available for enrollment, for those interested

[ Archived Issues / Search ]

This e-zine featured at EzineCenter.com -- the Ezine Search engine(tm)-- http://www.ezinecenter.com/
Johns Hopkins
Breast Center